Your browser doesn't support javascript.
loading
Enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade for recurrence following radical treatment in Japan (Japanese research for patients with non-metastatic castration-resistant prostate cancer-enzalutamide: JCASTRE-zero)-a prospective single-arm interventional study.
Sugimoto, Mikio; Kato, Takuma; Tohi, Yoichiro; Shimizu, Yosuke; Matsumoto, Ryuji; Inoue, Takahiro; Takezawa, Yutaka; Masui, Kimihiko; Sasaki, Hiroshi; Hirama, Hiromi; Saito, Shiro; Egawa, Shin; Kamoto, Toshiyuki; Teramukai, Satoshi; Kojima, Shinsuke; Kikuchi, Takashi; Kakehi, Yoshiyuki.
Affiliation
  • Sugimoto M; Department of Urology, Faculty of Medicine, Kagawa University, 1750-1, Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan. sugimoto.mikio@kagawa-u.ac.jp.
  • Kato T; Department of Urology, Faculty of Medicine, Kagawa University, 1750-1, Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan.
  • Tohi Y; Department of Urology, Faculty of Medicine, Kagawa University, 1750-1, Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan.
  • Shimizu Y; Department of Urology, Kobe City Nishi-Kobe Medical Center, Kobe, Hyogo, Japan.
  • Matsumoto R; Department of Urology, Hokkaido University Graduate School of Medicine, Hokkaido, Japan.
  • Inoue T; Department of Urology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Takezawa Y; Department of Urology, Isesaki Municipal Hospital, Isesaki, Gunma, Japan.
  • Masui K; Department of Urology, Otsu City Hospital, Otsu, Shiga, Japan.
  • Sasaki H; Department of Urology, Jikei University School of Medicine, Tokyo, Japan.
  • Hirama H; Department of Urology, Faculty of Medicine, Kagawa University, 1750-1, Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan.
  • Saito S; Department of Urology, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
  • Egawa S; Department of Urology, Jikei University School of Medicine, Tokyo, Japan.
  • Kamoto T; Department of Urology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
  • Teramukai S; Department of Biostatistics, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Kojima S; Foundation for Biomedical Research and Innovation at Kobe Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan.
  • Kikuchi T; Foundation for Biomedical Research and Innovation at Kobe Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan.
  • Kakehi Y; Department of Urology, Faculty of Medicine, Kagawa University, 1750-1, Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan.
BMC Urol ; 22(1): 151, 2022 Sep 14.
Article in En | MEDLINE | ID: mdl-36104667
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostate-Specific Antigen / Prostatic Neoplasms, Castration-Resistant Type of study: Guideline / Observational_studies / Risk_factors_studies Limits: Humans / Male Country/Region as subject: Asia Language: En Journal: BMC Urol Journal subject: UROLOGIA Year: 2022 Document type: Article Affiliation country: Japan Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostate-Specific Antigen / Prostatic Neoplasms, Castration-Resistant Type of study: Guideline / Observational_studies / Risk_factors_studies Limits: Humans / Male Country/Region as subject: Asia Language: En Journal: BMC Urol Journal subject: UROLOGIA Year: 2022 Document type: Article Affiliation country: Japan Country of publication: United kingdom